Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult)

NACompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

November 29, 2021

Primary Completion Date

January 13, 2023

Study Completion Date

January 13, 2023

Conditions
Attention Deficit Hyperactivity Disorder
Interventions
OTHER

Digital Treatment

"AKL-T01 multitasking digital treatment. AKL-T01 multitasking treatment employs perceptual discrimination attention/memory task as well as a continuous motor driving task."

Trial Locations (14)

27606

MindPath Care Centers, Raleigh

32751

Accel Research Sites, Maitland

33016

Behavioral Clinical Research, Inc., Miami Lakes

33319

Innovative Clinical Research, Inc., Lauderhill

63304

Midwest Research Group, Saint Charles

68526

Alivation Research, Lincoln

73106

IPS Research, Oklahoma City

75231

FutureSearch Trials, Dallas

77089

Southeast Houston Research, Inc., Houston

85254

Melmed Center, Scottsdale

87109

Albuquerque Neuroscience, Inc., Albuquerque

89128

Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas

92845

CNS Clinical Research Trials, Garden Grove

08009

Hassman Research Institute, Berlin

All Listed Sponsors
lead

Akili Interactive Labs, Inc.

INDUSTRY

NCT05183919 - Software Treatment for Actively Reducing Severity of ADHD in Adults (STARS ADHD Adult) | Biotech Hunter | Biotech Hunter